Osteopontin (OPN), another glycoprotein that is elevated in various cancers, including HCC, has gained attention for its ability to distinguish between HCC and benign liver diseases, which may help reduce false-positive diagnoses [26]. This evidence concerns the gene SPP1 and hepatocellular carcinoma.